Allergy Therapeutics appoints Nick Wykeman as finance director
Mr. Wykeman was most recently at Skyepharma PLC until August 2015 where he was the Group Financial Controller for six years.
Prior to that, he had also worked at Quest International (a part of ICI PLC) as the Group Financial Controller (Special Projects), following six years at Deloitte & Touche.
Mr. Wykeman has a BSc (Hons) in Economics and is a qualified accountant, being a member of the Institute of Chartered Accountants of England and Wales. ■
LATEST MOVES FROM United Kingdom
- Town Centre Securities appoints Mark Dilley as finance director
- Plus500 promotes Penelope Judd to chairman
- IGas Energy appoints two to board
- EVR Holdings appoints Ian Hanson as director
- Morgan Sindall Group appoints Tracey Killen as director
More inside POST